Aesthetic Medicine Market Size By Type (Non-surgical, Surgical), By Product (Energy-based {Laser-based Aesthetic Device, Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device}, Non Energy-based {Botulinum To

Aesthetic Medicine Market Size By Type (Non-surgical, Surgical), By Product (Energy-based {Laser-based Aesthetic Device, Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device}, Non Energy-based {Botulinum Toxin, Dermal Fillers, Implants [Facial Implants, Breast Implants]}), By Gender (Male {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}, Female {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}), By End-use (Hospitals, Ambulatory Surgical Centres, Beauty Centres & Medical Spas, Dermatology Clinics, Home Settings), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

Global Aesthetic Medicine Market is anticipated to experience robust growth through 2032, primarily due to the technological advancements associated with medical aesthetic devices. Besides, innovations in surgical and non-surgical aesthetic procedures such as fillers, photo rejuvenation, microdermabrasion, and cellulite therapies will positively impact the aesthetic medicine market growth.

Overall, the aesthetic medicine market is categorized on the basis of end-use, product, gender, type, and region.

Based on product, the market is likely to be driven by the energy-based segment. Energy-based aesthetic devices are chiefly used in minimally invasive procedures. Apart from the existing companies, new firms are also coming up with novel devices that impart aesthetic benefits with better efficacy and minimal invasion. These new devices have a range of applications such as hair removal, liposuction, scar treatment, non-surgical fat reduction, and body contouring. Increasing demand for such services is anticipated to drive market growth between 2023 and 2032.

In the context of type, the aesthetic medicine market is likely to be defined through the non-surgical segment, which will grow at a steady rate. The non-surgical treatments avert the complications and risks of traditional surgical treatments, enabling aesthetic improvements. Besides, non-surgical anti-aging procedures such as skin rejuvenation procedures and laser therapy are mostly suitable for the geriatric group as surgical treatments can have dire consequences such as delayed recovery time and procedural risks.

On the basis of end-use, the market is likely to be driven by the home settings segment. The segment churned out more than USD 2.2 billion revenue in 2022. There is an innate urge within the female population to look beautiful and young which, along with the growing belief that confidence and self-esteem are connected with aesthetic treatments, which will augment the market growth through the estimated timeframe.

Based on gender, the aesthetic medicine market is likely to be characterized by the female segment, which accounted for a higher market share in 2022 owing to increasing adoption of facial surgeries such as blepharoplasty, rhinoplasty, and breast augmentation procedures amongst women. Furthermore, surging technological advancements in non-invasive fat reduction procedures will further accelerate the market growth.

In the regional context, the aesthetic medicine market in Europe is expected to grow at a robust rate. The market in this region is anticipated to reach more than USD 9.2 billion by end of 2032. The driving factors behind the growth include the rapidly expanding rejuvenation centers, beauty centers, and aestheticians’ offices.

Some of the key players, currently operating in the market include Galderma, PhotoMedex, Merz Pharmaceuticals, Bausch Health Companies Inc., Allergan, Syneron Candela, Lumenis Inc., Alma Lasers, Johnson & Johnson, Cutera, Inc., and Cynosure.